SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-048145
Filing Date
2021-09-16
Accepted
2021-09-16 17:13:17
Documents
17
Period of Report
2021-09-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20210915.htm   iXBRL 8-K 46826
2 EX-1.1 life-ex11_50.htm EX-1.1 314715
3 EX-5.1 life-ex51_32.htm EX-5.1 17744
4 EX-99.1 life-ex991_31.htm EX-99.1 13040
5 GRAPHIC gppclvkmtwzl000001.jpg GRAPHIC 10916
6 GRAPHIC gdnptdff1j4p000001.jpg GRAPHIC 33607
  Complete submission text file 0001564590-21-048145.txt   656827

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA life-20210915.xsd EX-101.SCH 5693
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20210915_lab.xml EX-101.LAB 19335
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20210915_pre.xml EX-101.PRE 11492
10 EXTRACTED XBRL INSTANCE DOCUMENT life-8k_20210915_htm.xml XML 3550
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 211258604
SIC: 2836 Biological Products, (No Diagnostic Substances)